Charles River Laboratories (CRL) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $184.22 +1.47%
Revenue Growth %: -5.1%
Financial Fact:
Interest income: 523K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -5.1%
Financial Fact:
Interest income: 523K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $286 million versus the consensus estimate of $286.21 million.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Creatd files Form S-1 and reports Q1 2026 financial results
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
